KaveetaParikhVasishtMDPharmD

Diabetes, Lipid Metabolism

Associate Commissioner, Director-FDA Office of Women’s Health.

Dr. Vasisht is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of ChicagoFellowship, Endocrinology, Diabetes, and Metabolism, 2007 - 2010
University of ChicagoResidency, Internal Medicine, 2003 - 2006
Rutgers Robert Wood Johnson Medical SchoolClass of 2003

PubMed

21 citations
Enhancing Diversity and Inclusion in Clinical Trials.
Amy Corneli, Emily Hanlen-Rosado, Kevin McKenna, Richardae Araojo, Dawn Corbett
Clinical Pharmacology and Therapeutics. 2023-03-01
6 citations
Promoting Clinical Trial Diversity: A Highlight of Select US FDA Initiatives.
Anuradha Ramamoorthy, Richardae Araojo, Kaveeta P Vasisht, Mathilda Fienkeng, Dionna J Green
Clinical Pharmacology and Therapeutics. 2023-03-01
4 citations
Determinants of Hormone Replacement Therapy Knowledge and Current Hormone Replacement Therapy Use.
Laurén A Doamekpor, Sara K Head, Erin South, Christina Louie, Stanislav Zakharkin
Journal of Women's Health. 2023-03-01

Journal Articles

Progress and opportunities for women in clinical trials: A look at recent data and initiatives from the U.S. FDA
Kaveeta P. Vasisht, Bridget M. Nugent, Janet Woodcock, Med, 5/14/2021